BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luiz MT, Delello Di Filippo L, Tofani LB, de Araújo JTC, Dutra JAP, Marchetti JM, Chorilli M. Highlights in targeted nanoparticles as a delivery strategy for glioma treatment. Int J Pharm 2021;604:120758. [PMID: 34090991 DOI: 10.1016/j.ijpharm.2021.120758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Nikolaeva ME, Nechaev AV, Shmendel EV, Akasov RA, Maslov MA, Mironov AF. New Cysteine-Containing PEG-Glycerolipid Increases the Bloodstream Circulation Time of Upconverting Nanoparticles. Molecules 2022;27:2763. [PMID: 35566114 DOI: 10.3390/molecules27092763] [Reference Citation Analysis]
2 Qu C, Dong W. Polysaccharides Extracted from Angelica sinensis (Oliv.) Diels Relieve the Malignant Characteristics of Glioma Cells through Regulating the MiR-373-3p-Mediated TGF-β/Smad4 Signaling Pathway. Evid Based Complement Alternat Med 2022;2022:7469774. [PMID: 35855826 DOI: 10.1155/2022/7469774] [Reference Citation Analysis]
3 Duskey JT, Rinaldi A, Ottonelli I, Caraffi R, De Benedictis CA, Sauer AK, Tosi G, Vandelli MA, Ruozi B, Grabrucker AM. Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics 2022;14:1450. [DOI: 10.3390/pharmaceutics14071450] [Reference Citation Analysis]
4 Taiarol L, Formicola B, Fagioli S, Sierri G, D'Aloia A, Kravicz M, Renda A, Viale F, Dal Magro R, Ceriani M, Re F. The 3.0 Cell Communication: New Insights in the Usefulness of Tunneling Nanotubes for Glioblastoma Treatment. Cancers (Basel) 2021;13:4001. [PMID: 34439156 DOI: 10.3390/cancers13164001] [Reference Citation Analysis]
5 Lan QH, Du CC, Yu RJ, Zhai J, Shi Y, Kou L, Xiao J, Lu CT, Zhao YZ, Yao Q. Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy. Int J Pharm 2021;607:120978. [PMID: 34371152 DOI: 10.1016/j.ijpharm.2021.120978] [Reference Citation Analysis]